Log out

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 1125 N. Charles St, Baltimore, MD 21201.

Ra Pharmaceuticals Inc (RARX)

$48.00 0.00 (0.00%)

19:32 EDT RARX Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 1.55B

PE Ratio -19.05

EPS -2.52

Volume (Avg. Vol.)

Day's Range 48.00 - 48.00

52-Week Range 22.25 - 48.02

Dividend & Yield N/A (N/A)

RARX Stock Predictions, Articles, and Ra Pharmaceuticals Inc News

From InvestorPlace
From the Web

Ra Pharmaceuticals News: RARX Stock Flies 100% on $2.1 Billion UCB Deal

By William White, InvestorPlace Writer Oct 10, 2019

Ra Pharmaceuticals (NRARX) is seeing its stock take off on Thursday following news of a deal with UCB (UCBJF) valued at $2.10 billion.

5 Clinical-Stage Biotech Stocks to Buy

By Aaron Levitt, InvestorPlace Contributor Feb 25, 2019

There are plenty of potential in clinical-stage biotech stocks. Here are five with some wonderful catalysts.

5 Clinical-Stage Biotech Stocks to Buy Under $10

By Aaron Levitt, InvestorPlace Contributor May 29, 2018

Clinical-stage biotech stocks offer plenty of promise to investors looking to take on some risk. Here are five to buy today.

Misonix to Report Fiscal 2020 Fourth Quarter Financial Results and Host Conference Call and Webcast on September 3

From BusinessInsider Aug 6, 2020

FARMINGDALE, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medic...

Misonix (MSON) Gets a Buy Rating from BTIG

From Analyst Ratings Jul 10, 2020

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Misonix (MSON – Research Report), with a price target of $18.00. The company’s shares closed last Thursday at $10.95. According to TipRanks.com, Zimmerman is a 4-star analyst with an average return of 10.3% and a 48.1% success rate. Zimmerman covers the

Misonix Inc (MSON) Q3 2020 Earnings Call Transcript

From The Motley Fool May 12, 2020

MSON earnings call for the period ending March 31, 2020.

Analysts Offer Insights on Healthcare Companies: Theratechnologies (NASDAQ: THTX), Misonix (NASDAQ: MSON) and Zymeworks (NYSE: ZYME)

From Analyst Ratings Jul 13, 2020

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Theratechnologies (THTX – Research Report), Misonix (MSON – Research Report) and Zymeworks (ZYME – Research Report) with bullish sentiments. Theratechnologies (THTX) Canaccord Genuity analyst Edward Nash maintained a Buy rating on Theratechnologies on July 10 and set

65 Biggest Movers From Friday

From Benzinga Jul 13, 2020

Gainers Hermitage Offshore Services Ltd. (NYSE: PSV) shares jumped 285.3% to close at $1.88 on Friday after the company announced a forbearance agreement with lenders to its $132...

44 Stocks Moving In Friday's Mid-Day Session

From Benzinga Jul 10, 2020

Gainers Hermitage Offshore Services Ltd. (NYSE: PSV) shares surged 112.1% to $1.0350 after the company announced a forbearance agreement with lenders to its $132.9 million term...